Our Board members
Click on the board member to get more details
Our board members bring a wealth of knowledge and insights from several fields that help quide the PharmaLedger Association in achieving its vision of enabling a Digital Trust Ecosystem in Healthcare (DTE-H) to solve problems that can’t be solved by single organizations.
Board members serve a 3-year term and have assigned responsibilities:
- Preparation and execution of ordinary and extraordinary
- General Assemblies
- Proposal of amendment of the bylaws
- Adoption of Organizational Regulations
- Preparation of annual report
- The signing of contracts with Service Providers
PLA Board Member
Brian M. Thornley
Chairman of the Board
Daniel Fritz
Executive Director
Jeanne Barnett
PLA Board Member
Sarah Bevan
PLA Board Member
María Teresa Arredondo Waldmeyer
PLA Board Member
Christian Mondini
PLA Board Member
René Kronenburg
PLA Board Member
Brian M. Thornley | MSD
Chairman of the Board
“The vision of PharmaLedger is to help establish a backbone for the Pharmaceutical Supply Chain digital twin, providing robust, secure, and compliant connectivity with the entire healthcare value chain, including regulators for product release and connectivity to distributors all the way to clinics and patients. In time, this blockchain based ecosystem will provide trusted, secure information at the point of dispensing, validate the provenance of the product, ease transportation and distribution to the clinic and provide vital patient information, enabling the visibility, security, and traceability of a more resilient global healthcare supply chain”
ABOUT BRIAN Brian M. Thornley leads the global supply strategy from plant to patient. He oversees Merck’s digital supply chain strategy including blockchain enabled pharma, organization development and enterprise segmentation to optimize service, cost, earnings and return on capital employed. Previously he acted AVP Supply Chain Operations EMEA & AP, including Planning and Strategy for Merck MSD, developing the strategic approach to deliver internal efficiencies and external transformation of the supply chain from factories to end customer.
Daniel Fritz | PLA
Executive Director“Blockchain is a team sport. PLA has started with a diverse and strong team of members who share a common vision and who believe in real change. With PLA we have the right vehicle, resources, and roadmap to take patients to a better place in healthcare.”
ABOUT DAN
Dan served as the Industry Project Leader for the PharmaLedger Project. He was with Novartis for over 20 years in global supply chain, manufacturing operations and systems architecture in Switzerland and Germany. He has more than 30 years of leadership and supply chain IT experience in the US Army, financial, and pharmaceutical industries. He holds a B.S. in Engineering Management from the United States Military Academy at West Point and an MBA from Duke’s Fuqua School of Business and is certified by ASCM in CPIM, CSCP and SCOR.Sarah Bevan | GSK
PLA Board Member“GSK, as a lead member of PLA, looks forward to the industry wide collaboration enabling a healthcare digital ecosystem. We believe that the PLA initiative complements our ongoing plans to achieve more for patients through digital.”
ABOUT SARAH
Sarah is a Supply Chain professional at GSK, leading Artwork , Packaging & Serialisation Services. She has 20+ years’ experience in the Pharmaceutical Industry spanning Manufacturing, SC, Tech and Finance. Strong expertise in business transformation supported by technology and optimized operating models including outsourced services. Her passion is leading teams to provide excellent service performance, generating and executing strategic plans to benefit patients.Hannes Jarke | EPF
PLA Board Member“Blockchain technology has the potential to help people keeping their health data secure and anonymous while still being able to profit from personalised solutions. Having patient representatives and patient engagement experts at the table of the PharmaLedger Association provides a unique chance to adjust blockchain enabled healthcare solutions to patient needs early in the process. It is my hope for the Association that this involvement will also support the development of resources for a wider public understanding of how blockchain functions, supporting citizens in making well-informed decisions when it comes to their health data.”
ABOUT HANNES
A psychologist and public health professional by training, Hannes’ career is focused on improving population health through initiatives combining research, the translation of research findings into tangible insights for policy and lay people, and advocacy. He is specialised in managing international and transdisciplinary projects that bring together stakeholders from all areas. Hannes led the European Patients’ Forum’s contributions to the PharmaLedger project which made him passionate about patient-centricity in the development of Electronic Product Information; as well as establishing a shared clinical trial matchmaking platform. His vision for the PLA is for it to grow into a transparent and collaborative consortium that accelerates the development and deployment of blockchain-enabled healthcare where patient and citizen perspectives continue to shape products in all stages.René Kronenburg | AbbVie
PLA Board Member“After co-leading the Development and Implementation of the PharmaLedger Use Cases I am honored to be elected to the PLA board. PharmaLedger proved that collaboration between different companies using blockchain technology creates excellent and unique solutions, which benefit patients worldwide. These solutions would not be possible if developed by one single company or without these tools. My goal for PharmaLedger Association is to materialize on all the knowledge and results from the PharmaLedger Project by deploying all existing and new Use Cases to impact the life of patients.”
Christian Mondini | Concorzio Dafne
PLA Board Member“I’m honored to have the opportunity to join the Board of Directors of PharmaLedger Association. I look forward to contributing to the development of a Digital Trust Ecosystem for the Healthcare industry.”
ABOUT CHRISTIAN
Management Engineer and MBA at MIP Politecnico di Milano Graduate School of Business, from July 2018 he is a Digital Business independent Advisor, helping companies in implementing new technologies to support their digital transformation (both at a strategic and operational level). Currently he is Head of Innovation and Operations at Consorzio Dafne, the reference non-profit B2B Community for the Italian Healthcare industry. His past experiences include research, advisory, Product Management and startups mentorships in the field of new technologies (Mobile & IoT, Blockchain, Augmented & Extended Reality, …)María Teresa Arredondo Waldmeyer | Activage.org
PLA Board Member“Being agnostic of technology and focusing on improving business processes make us free from technological limitations. PharmaLedger Association is about keeping the eyes on common goals, while taking the next step towards moving together as a multistakehoder group of organizations that can collaborate and work together in trusted ecosystems. We want at our very core to jump into a real trusted collaboration and innovation among different types of organizations (industry, associations, Research, etc) in Healthcare. As a non-profit organization, ACTIVAGE supports on understanding people through this collaboration, taking this opportunity to really make a difference for people and patients”
ABOUT MARÍA TERESA
Considered as one of the 8 pioneers who opened the doors to thousands of scientist women in Spain. She is the first woman Electronic Engineer (National University of Tucumán), first PhD in Telecommunications Engineering (Universidad Politecnica de Valencia). First Full Professor in Telecommunication Engineering (Universidad Politécnica de Madrid). First woman professor in Electronic Technology in Spain. Also, she is one of the 7 founders of the First Scientific Society of Bioengineering (SABI) of all Latin America. Recognised by the Valencia Official College of Engineers (COITCV/AVIT) as one of the women in the sector who have most influenced the development of ICTs. She created the Life Supporting Technologies (LST) Research Group in 2022 and has led 110 European Projects as PI (FP6; FP7; H2020; EIT HEALTH; IMI; PRIMA).Jeanne Barnett | CF Technology
PLA Board Member“CFTechnology.org’s goal is to provide the cystic fibrosis community with education and technology, such as mobile health devices. This is only possible through strong collaboration and a common focus on the patient. The PharmaLedger Association creates new opportunities for us to accelerate digital transformation of healthcare for patients. We are happy to be part of the team!”
ABOUT JEANNE
A well-versed patient advocate with a pioneering sense of the web’s potential to improve health care, Jeanne’s expertise has been honed through years of broad-based experience. She understands the complex issues patients with cystic fibrosis face. She is an expert in creating effective patient-centered website forums, videos, newsletters, podcasts, apps, and new technologies for patient education and self-care management. She is skilled in preparing and delivering comprehensive presentations to varied audiences including Pharma Conferences. She has chaired and delivered presentations at Digital Pharma East and eyeforpharma conferences. Jeanne won the Patient Centricity Award in 2011 from PharmaPhorum. She has a teacher’s patience and curiosity. Jeanne identifies and addresses the needs of patients requiring innovative technological solutions. Detail-oriented with proven effectiveness in stimulating the patient base. Experienced with twenty five years of listening to patients’ stories. Proactive in promoting the implementation of remote technology solutions, reducing cross contamination health risks and ultimately reducing chronic care costs.John A. Graham | Zuellig Pharma
PLA Board Member“I am honoured to join the PharmaLedger Association (PLA) Board of Directors and look forward to providing unique insights drawn from decades of working across different areas of the healthcare value chain in order to build a patient-first ecosystem with meaningful innovations and technologies.”
ABOUT JOHN
John is a senior healthcare executive and leader, with more than 30 years of global experience in the pharma/biotech industry. A recognized expert across many dimensions of the industry and currently serves as Chief Executive Office at Zuellig Pharma John joined Zuellig Pharma in 2018 to oversee the development and growth of their Commercial Solutions business, spearheading the growth of its marketing, sales, business development, and regulatory services. John has over three decades of industry experience in biotech, pharmaceuticals, strategy consulting, and healthcare investment banking across Europe, Asia, Latin America, and the United States. He previously held various senior global leadership positions at Aventis, Genzyme, and Ernst & Young, as well as the role of CEO at Menarini Asia-Pacific based in Singapore, where he established the company’s Asia-Pacific commercial footprint.Our Board Members
Our board members bring a wealth of knowledge and insights from several fields that help quide the PharmaLedger Association in achieving its vision of enabling a Digital Trust Ecosystem in Healthcare (DTE-H) to solve problems that can’t be solved by single organizations.
Board members serve a 3-year term and have assigned responsibilities:
- Preparation and execution of ordinary and extraordinary General Assemblies
- Proposal of amendment of the bylaws
- Adoption of Organizational Regulations
- Preparation of annual report
- The signing of contracts with Service Providers
Click on the board members below to get more details:
Chair of the Board
Executive Director
PLA Board Member
PLA Board Member
PLA Board Member
PLA Board Member
PLA Board Member
John A. Graham
PLA Board Member
Brian M. Thornley | MSD
Chairman of the Board
“The vision of PharmaLedger is to help establish a backbone for the Pharmaceutical Supply Chain digital twin, providing robust, secure, and compliant connectivity with the entire healthcare value chain, including regulators for product release and connectivity to distributors all the way to clinics and patients. In time, this blockchain based ecosystem will provide trusted, secure information at the point of dispensing, validate the provenance of the product, ease transportation and distribution to the clinic and provide vital patient information, enabling the visibility, security, and traceability of a more resilient global healthcare supply chain”
ABOUT BRIAN
Brian M. Thornley leads the global supply strategy from plant to patient. He oversees Merck’s digital supply chain strategy including blockchain enabled pharma, organization development and enterprise segmentation to optimize service, cost, earnings and return on capital employed. Previously he acted AVP Supply Chain Operations EMEA & AP, including Planning and Strategy for Merck MSD, developing the strategic approach to deliver internal efficiencies and external transformation of the supply chain from factories to end customer.
Daniel Fritz | PLA
Executive Director
“Blockchain is a team sport. PLA has started with a diverse and strong team of members who share a common vision and who believe in real change. With PLA we have the right vehicle, resources, and roadmap to take patients to a better place in healthcare.”
ABOUT DAN
Dan served as the Industry Project Leader for the PharmaLedger Project. He was with Novartis for over 20 years in global supply chain, manufacturing operations and systems architecture in Switzerland and Germany. He has more than 30 years of leadership and supply chain IT experience in the US Army, financial, and pharmaceutical industries. He holds a B.S. in Engineering Management from the United States Military Academy at West Point and an MBA from Duke’s Fuqua School of Business and is certified by ASCM in CPIM, CSCP and SCOR.
Sarah Bevan | GSK
PLA Board Member
“GSK, as a lead member of PLA, looks forward to the industry wide collaboration enabling a healthcare digital ecosystem. We believe that the PLA initiative complements our ongoing plans to achieve more for patients through digital.”
ABOUT SARAH
Sarah is a Supply Chain professional at GSK, leading Artwork , Packaging & Serialisation Services. She has 20+ years’ experience in the Pharmaceutical Industry spanning Manufacturing, SC, Tech and Finance. Strong expertise in business transformation supported by technology and optimized operating models including outsourced services. Her passion is leading teams to provide excellent service performance, generating and executing strategic plans to benefit patients.
Hannes Jarke | EPF
PLA Board Member
“Blockchain technology has the potential to help people keeping their health data secure and anonymous while still being able to profit from personalised solutions. Having patient representatives and patient engagement experts at the table of the PharmaLedger Association provides a unique chance to adjust blockchain enabled healthcare solutions to patient needs early in the process. It is my hope for the Association that this involvement will also support the development of resources for a wider public understanding of how blockchain functions, supporting citizens in making well-informed decisions when it comes to their health data.”
ABOUT HANNES
A psychologist and public health professional by training, Hannes’ career is focused on improving population health through initiatives combining research, the translation of research findings into tangible insights for policy and lay people, and advocacy. He is specialised in managing international and transdisciplinary projects that bring together stakeholders from all areas. Hannes led the European Patients’ Forum’s contributions to the PharmaLedger project which made him passionate about patient-centricity in the development of Electronic Product Information; as well as establishing a shared clinical trial matchmaking platform. His vision for the PLA is for it to grow into a transparent and collaborative consortium that accelerates the development and deployment of blockchain enabled healthcare where patient and citizen perspectives continue to shape products in all stages.
René Kronenburg | AbbVie
PLA Board Member
“After co-leading the Development and Implementation of the PharmaLedger Use Cases I am honored to be elected to the PLA board. PharmaLedger proved that collaboration between different companies using blockchain technology creates excellent and unique solutions, which benefit patients worldwide. These solutions would not be possible if developed by one single company or without these tools. My goal for PharmaLedger Association is to materialize on all the knowledge and results from the PharmaLedger Project by deploying all existing and new Use Cases to impact the life of patients.”
Christian Mondini | Concorzio Dafne
PLA Board Member
“I’m honored to have the opportunity to join the Board of Directors of PharmaLedger Association. I look forward to contributing to the development of a Digital Trust Ecosystem for the Healthcare industry.”
ABOUT CHRISTIAN
Management Engineer and MBA at MIP Politecnico di Milano Graduate School of Business, from July 2018 he is a Digital Business independent Advisor, helping companies in implementing new technologies to support their digital transformation (both at a strategic and operational level). Currently he is Head of Innovation and Operations at Consorzio Dafne, the reference non-profit B2B Community for the Italian Healthcare industry. His past experiences include research, advisory, Product Management and startups mentorships in the field of new technologies (Mobile & IoT, Blockchain, Augmented & Extended Reality, …)
María Teresa Arredondo Waldmeyer | Activage.org
PLA Board Member
“Being agnostic of technology while focusing on improving business processes makes us free from technological limitations. The PharmaLedger Association is about keeping our eyes on common goals, while taking the next step together as a multistakehoder group of organizations that can collaborate in trusted ecosystems. We want at our very core to jump into real, trusted collaboration and innovation among different types of organizations (industry, associations, research, etc.) in healthcare. As a non-profit organization, ACTIVAGE prioritizes understanding people through this collaboration, taking this opportunity to make a real difference for people and patients.“
ABOUT MARÍA TERESA
Considered as one of the 8 pioneers who opened the doors to thousands of scientist women in Spain. She is the first woman Electronic Engineer (National University of Tucumán), first PhD in Telecommunications Engineering (Universidad Politecnica de Valencia). First Full Professor in Telecommunication Engineering (Universidad Politécnica de Madrid). First woman professor in Electronic Technology in Spain. Also, she is one of the 7 founders of the First Scientific Society of Bioengineering (SABI) of all Latin America. Recognised by the Valencia Official College of Engineers (COITCV/AVIT) as one of the women in the sector who have most influenced the development of ICTs. She created the Life Supporting Technologies (LST) Research Group in 2022 and has led 110 European Projects as PI (FP6; FP7; H2020; EIT HEALTH; IMI; PRIMA).
Jeanne Barnett | CF Technology
PLA Board Member
“CFTechnology.org’s goal is to provide the cystic fibrosis community with education and technology, such as mobile health devices. This is only possible through strong collaboration and a common focus on the patient. The PharmaLedger Association creates new opportunities for us to accelerate digital transformation of healthcare for patients. We are happy to be part of the team!” – Jeanne Barnett, CEO CFTechnology.org”
ABOUT JEANNE
A well-versed patient advocate with a pioneering sense of the web’s potential to improve health care, Jeanne’s expertise has been honed through years of broad-based experience. She understands the complex issues patients with cystic fibrosis face. She is an expert in creating effective patient-centered website forums, videos, newsletters, podcasts, apps, and new technologies for patient education and self-care management. Jeanne won the Patient Centricity Award in 2011 from PharmaPhorum. Jeanne identifies and addresses the needs of patients requiring innovative technological solutions. Detailoriented with proven effectiveness in stimulating the patient base. Experienced with twenty five years of listening to patients’ stories. Proactive in promoting the implementation of remote technology solutions, reducing cross contamination health risks and ultimately reducing chronic care costs.
John A. Graham | Zuellig Pharma
PLA Board Member
“I am honoured to join the PharmaLedger Association (PLA) Board of Directors and look forward to providing unique insights drawn from decades of working across different areas of the healthcare value chain in order to build a patient-first ecosystem with meaningful innovations and technologies.”
ABOUT JOHN
John is a senior healthcare executive and leader, with more than 30 years of global experience in the pharma/biotech industry. A recognized expert across many dimensions of the industry and currently serves as Chief Executive Office at Zuellig Pharma John joined Zuellig Pharma in 2018 to oversee the development and growth of their Commercial Solutions business, spearheading the growth of its marketing, sales, business development, and regulatory services. John has over three decades of industry experience in biotech, pharmaceuticals, strategy consulting, and healthcare investment banking across Europe, Asia, Latin America, and the United States. He previously held various senior global leadership positions at Aventis, Genzyme, and Ernst & Young, as well as the role of CEO at Menarini Asia-Pacific based in Singapore, where he established the company’s Asia-Pacific commercial footprint.